Hipertensión resistente en enfermedad renal terminal pediátrica

Virginia Martínez-Santana; Silvia Marique-Rodríguez; Ana Belén Martínez; Olalla Álvarez

doi:10.7399/fh.2014.38.6.7328

Hipertensión resistente en enfermedad renal terminal pediátrica

Virginia Martínez-Santana, Silvia Marique-Rodríguez, Ana Belén Martínez, Olalla Álvarez

Resumen

Palabras clave

Texto completo:

PDF (English)

Referencias

Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22(12):1999–2009. doi:10.1007/s00467-006-0410-1.

Fernández-Llamazares CM, Manrique-Rodríguez S, Sanjurjo-Sáez M. Drug use safety in paediatrics. Arch Argent Pediatr. 2011;109(6):510–518.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

Simonetti GD, Bucher BS, Tschumi S, et al. Arterial hypertension and proteinuria in pediatric chronic kidney disease. Minerva Pediatr. 2012;64(2):171–182.

Wühl E, Trivelli A, Picca S, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639–1650.

Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–1742.

Wingen AM, Fabian-Bach C, Schaefer F, et al. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet. 1997;349(9059):1117–1123.

Simonetti GD, Santoro L, Ferrarini A, et al. Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs. 2007;9(6):413–418.

DOI: http://dx.doi.org/10.7399%2Ffh.2014.38.6.7328